Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interactions between corticosteroids and beta2-agonists.

Robert J Hancox1

  • 1Department of Preventive and Social Medicine, Dunedin School of Medicine, Dunedin, New Zealand. bob.hancox@otago.ac.nz

Clinical Reviews in Allergy & Immunology
|November 7, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acute effects of low-dose bisoprolol on lung function and blood pressure in COPD patients.

ERJ open research·2026
Same author

Shaping lung health from the start: early-life trajectories and lifelong risk.

The European respiratory journal·2026
Same author

Social mobility and parenting: Testing associations in a prospective longitudinal cohort study.

Child development·2026
Same author

Bisoprolol to prevent adverse cardiac events (PACE) in COPD: a multicentre, double-blind, randomised, controlled, phase 3 trial.

The Lancet. Respiratory medicine·2026
Same author

Cost-effectiveness of as-needed budesonide-formoterol in adults with mild asthma: the Novel START trial.

ERJ open research·2026
Same author

Preconception Predictors of Next Generation Early Relational Health: A Living Review of Prospective Cohort Studies.

Clinical child and family psychology review·2025
Same journal

Therapeutic Targeting of the Bradykinin B2 Receptor in Immunological and Vascular Diseases: Insights from Kinin Biology to Clinical Outcomes.

Clinical reviews in allergy & immunology·2026
Same journal

β-blocker Therapy in Cholinergic Urticaria, Adrenergic Urticaria and the Aquagenic Continuum Beta-Blocker Therapy in Chronic Inducible Urticaria.

Clinical reviews in allergy & immunology·2026
Same journal

Immunopathogenesis and Cytokine Pathways in Reactive Infectious Mucocutaneous Eruption (RIME) in Pediatric Population: Infectious Triggers and Molecular Insights.

Clinical reviews in allergy & immunology·2026
Same journal

Neuropsychological Factors in Vitiligo: Mechanisms and Clinical Application.

Clinical reviews in allergy & immunology·2026
Same journal

Tertiary Lymphoid Structure: A Potential Therapeutic Target Affecting Immune Response in Autoimmune Diseases.

Clinical reviews in allergy & immunology·2026
Same journal

Differentiating Acute-onset Autoimmune Hepatitis From Drug-Induced Autoimmune-like Hepatitis: A Multicenter Study and Score Development.

Clinical reviews in allergy & immunology·2026
See all related articles

Combination therapy with inhaled corticosteroids and long-acting beta-agonists offers significant benefits for asthma management. While synergy is suggested, further research is needed to fully understand and optimize this effective treatment approach.

Area of Science:

  • Pharmacology
  • Respiratory Medicine
  • Clinical Therapeutics

Background:

  • In vitro studies suggest synergistic interactions between beta2-agonists and corticosteroids.
  • Combination therapy of inhaled corticosteroids and long-acting beta-agonists shows improved airway disease control compared to monotherapy.
  • In vivo evidence for a positive interaction or synergy between these drug classes is limited.

Purpose of the Study:

  • To evaluate the evidence for beneficial synergy between inhaled corticosteroids and beta2-agonists in airway diseases.
  • To determine if beta2-agonists enhance corticosteroid anti-inflammatory actions or if corticosteroids enhance bronchodilation.
  • To investigate the clinical benefits of combined inhaled corticosteroid/beta-agonist treatment in asthma.

Main Methods:

Related Experiment Videos

  • Review of in vitro and in vivo studies on drug interactions.
  • Analysis of clinical trial data comparing combination therapy with monotherapy.
  • Examination of evidence regarding tolerance development and reversal.

Main Results:

  • In vitro studies show potential for interaction, but in vivo evidence for synergy is weak.
  • Corticosteroids do not appear to enhance beta2-agonist bronchodilation or prevent tolerance.
  • Most clinical benefits of combination therapy may stem from additive or complementary effects.

Conclusions:

  • The precise nature of the interaction between inhaled corticosteroids and beta2-agonists requires further investigation.
  • Combined inhaled corticosteroid/beta-agonist treatment is a cornerstone of asthma management.
  • Optimizing combination therapy benefits and minimizing adverse effects remains an area for future research.